PRE IMPLANTATION GENETIC SCREENING FOR CHROMOSOMAL ABNORMALITIES

This improves your reproductive success with the specific selection of embryos which are chromosomally normal. This procedure allows us to analyze all 24 chromosome types in order to discard the possibility of embryonic aneuploidy (An abnormal number of chromosomes, either excessive or deficient) before implantation. With the use of array comparative genomic hybridization (aCGH), we are able to achieve very high percentage of informed embryos (98%) using only one embryonic cell Preimplantation Genetic Screening (PGS) allows the specific selection of embryos which are chromosomally normal before implantation

INDICATIONS

Advanced maternal age
Prior pregnancy or child with a chromosomal abnormality
Multiple implantation failures
Recurrent miscarriage
Severe male factor
PCOS and combined factors

PRE IMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A)

PGT-A, or preimplantation genetic testing for aneuploidies, is a genetic test performed on embryos produced through IVF. PGT-A gives information about embryos’ genetic health to help your care team select the best embryo for transfer and improve your chance of achieving a successful pregnancy. PGT-A was formerly known as PGS, preimplantation genetic screening.

INDICATIONS

Repeated failed IVF cycles;
Pregnancy occurs, but then repeatedly interrupted or stopped (Repeated miscarriages);
Age after 40 years (Advanced maternal age).
Changes in the parental karyotype (Robertsonian, reciprocal translocations or chromosomal mosaicism);